ALTHE — Theraclion SA Share Price
0.000.00%
Last trade - 00:00- €6.71m
- €2.43m
- €1.82m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.58 | ||
| Price to Tang. Book | 4.7 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 11.12 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -32.55% | ||
| Return on Equity | -92.66% | ||
| Operating Margin | -581.06% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 2.78 | 0.74 | 1.48 | 1.24 | 1.82 | 12 | n/a | -1.13% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Theraclion SA is a France-based company, which develops High Intensity Focused Ultrasound (HiFu) machines. The Company is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The Company provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
Directors
- Yann Duchesne CHM
- David Caumartin CEO
- Mehdi El Glaoui DRC
- Ari Kellen IND
- Shawn Langer IND
- Samuel Levy IND
- Renaud Saleur IND
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- August 3rd, 2004
- Public Since
- April 25th, 2014
- No. of Employees
- 28
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 45,675,998
- Address
- 244, avenue Pierre Brossolette, MALAKOFF, 92240
- Web
- https://www.theraclion.fr/
- Phone
- +33 155489070
- Auditors
- Ernst & Young Audit
Upcoming Events for ALTHE
Half Year 2025 Theraclion SA Corporate Sales Release
Similar to ALTHE
AbL Diagnostics SA
Euronext - Paris
Affluent Medical SAS
Euronext - Paris
Amplitude Surgical SA
Euronext - Paris
Aton SA
Euronext - Paris
Biomerieux SA
Euronext - Paris
FAQ
What is the Theraclion SA share price?
As of Today at 23:39 UTC, shares in Theraclion SA are trading at €0.15. This share price information is delayed by 15 minutes.
How has the Theraclion SA share price performed this year?
Shares in Theraclion SA last closed at €0.15 and the price had moved by -59.67% over the past 365 days. In terms of relative price strength the Theraclion SA share price has underperformed the FTSE Global All Cap Index by -60.68% over the past year.
What are the analyst and broker recommendations for Theraclion SA?
The overall consensus recommendation for Theraclion SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Theraclion SA dividend yield?
Theraclion SA does not currently pay a dividend.
Does Theraclion SA pay a dividend?
Theraclion SA does not currently pay a dividend.
When does Theraclion SA next pay dividends?
Theraclion SA does not currently pay a dividend.
How do I buy Theraclion SA shares?
To buy shares in Theraclion SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Theraclion SA?
As of the previous close price of €0.15, shares in Theraclion SA had a market capitalisation of €6.71m.
Where are Theraclion SA shares listed?
Here are the trading details for Theraclion SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALTHE
What kind of share is Theraclion SA?
Based on an overall assessment of its quality, value and momentum Theraclion SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Theraclion SA share price forecast for 2025?
The analyst consensus target price for shares in Theraclion SA is €4.00. That is 2624.8% above the last closing price of €0.15.
Analysts covering Theraclion SA currently have a consensus Earnings Per Share (EPS) forecast of €0.10 for the next financial year.
Find out moreWhat is the trend in the Theraclion SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Theraclion SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -61.21%.
As of the last closing price of €0.15, shares in Theraclion SA were trading -50.17% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Theraclion SA PE Ratio?
The Theraclion SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.15.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Theraclion SA?
Theraclion SA's management team is headed by:
- Yann Duchesne - CHM
- David Caumartin - CEO
- Mehdi El Glaoui - DRC
- Ari Kellen - IND
- Shawn Langer - IND
- Samuel Levy - IND
- Renaud Saleur - IND